GE I-mIBG Study

Protocol Title:

A Multicenter, Phase 3, Open Label Study o f ¹²³I-mIBG Imaging to Identify Patients with Heart Failure who will Experience an Adverse Cardiac Event

Working Title:

This study is to demonstrate the prognostic usefulness of assessment of myocardial sympathetic innervation, as determined by the heart to mediastinum (H/M) ratio on planar 123I mIBG imaging as either normal or abnormal, for identifying heart failure (HF) subjects at higher risk of experiencing an adverse cardiac event.

Principal Investigator:

Daniel S. Berman, MD

IRB Approval Number:

7088

Medical Specialty Area:

Cardiac Imaging- SPECT

Condition/Disease:

Congestive Heart Failure

IRB Approval Expiration Date:

04/30/2008

Contact Information for patients wishing more information:

Name: Justin Henderson
Phone: (310) 423-2116
E-mail: HendersonJS@cshs.org